524 related articles for article (PubMed ID: 19651473)
21. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
22. Viral, immunologic, and clinical features of primary effusion lymphoma.
Lurain K; Polizzotto MN; Aleman K; Bhutani M; Wyvill KM; Gonçalves PH; Ramaswami R; Marshall VA; Miley W; Steinberg SM; Little RF; Wilson W; Filie AC; Pittaluga S; Jaffe ES; Whitby D; Yarchoan R; Uldrick TS
Blood; 2019 Apr; 133(16):1753-1761. PubMed ID: 30782610
[TBL] [Abstract][Full Text] [Related]
23. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
Liang Z; Qin Z; Riker AI; Xi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
26. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
Ramaswami R; Lurain K; Marshall VA; Rupert A; Labo N; Cornejo-Castro E; Miley W; Wang HW; Widell A; Lindsley M; Yuan C; Stetler-Stevenson M; Filie AC; Whitby D; Ziegelbauer JM; Uldrick TS; Yarchoan R
AIDS; 2021 Jan; 35(1):53-62. PubMed ID: 33273183
[TBL] [Abstract][Full Text] [Related]
27. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.
Dupin N; Fisher C; Kellam P; Ariad S; Tulliez M; Franck N; van Marck E; Salmon D; Gorin I; Escande JP; Weiss RA; Alitalo K; Boshoff C
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4546-51. PubMed ID: 10200299
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
[TBL] [Abstract][Full Text] [Related]
29. Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.
Naimo E; Zischke J; Schulz TF
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578378
[TBL] [Abstract][Full Text] [Related]
30. Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies.
Patel R; Lurain K; Yarchoan R; Ramaswami R
Expert Rev Anti Infect Ther; 2023; 21(9):929-941. PubMed ID: 37578202
[TBL] [Abstract][Full Text] [Related]
31. Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.
Cai Q; Verma SC; Lu J; Robertson ES
Adv Virus Res; 2010; 78():87-142. PubMed ID: 21040832
[TBL] [Abstract][Full Text] [Related]
32. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
33. 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.
Polizzotto MN; Millo C; Uldrick TS; Aleman K; Whatley M; Wyvill KM; O'Mahony D; Marshall V; Whitby D; Maass-Moreno R; Steinberg SM; Little RF; Yarchoan R
J Infect Dis; 2015 Oct; 212(8):1250-60. PubMed ID: 25828248
[TBL] [Abstract][Full Text] [Related]
34. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
Sakakibara S; Tosato G
J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
[TBL] [Abstract][Full Text] [Related]
35. Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma.
Burbelo PD; Issa AT; Ching KH; Wyvill KM; Little RF; Iadarola MJ; Kovacs JA; Yarchoan R
J Infect Dis; 2010 Jun; 201(12):1919-22. PubMed ID: 20443737
[TBL] [Abstract][Full Text] [Related]
36. HIV-associated Kaposi sarcoma and related diseases.
Gonçalves PH; Uldrick TS; Yarchoan R
AIDS; 2017 Sep; 31(14):1903-1916. PubMed ID: 28609402
[TBL] [Abstract][Full Text] [Related]
37. Concomitant Kaposi sarcoma and multicentric Castleman's disease in a heart transplant recipient.
Patel A; Bishburg E; Zucker M; Tsang P; Nagarakanti S; Sabnani I
Heart Lung; 2014; 43(6):506-9. PubMed ID: 25169666
[TBL] [Abstract][Full Text] [Related]
38. Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.
Gaidano G; Castaños-Velez E; Biberfeld P
Med Oncol; 1999 Apr; 16(1):8-12. PubMed ID: 10382936
[TBL] [Abstract][Full Text] [Related]
39. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
[TBL] [Abstract][Full Text] [Related]
40. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]